NASDAQ · MCVIX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
MFS Mid Cap Value Fund’s quoted price sits in the upper half of its reported 52-week range, 2.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
MFS Mid Cap Value Fund’s forward annual dividend is $2.55 per share, paid annual. The forward yield is 7.02% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund typically allocates a substantial majority—at least 80% of its net assets—to companies exhibiting medium market capitalizations. The fund's management defines these mid-cap entities as those with market values similar to the companies comprising the Russell Midcap® Value Index, based on their valuations over the prior 13 months at the time of investment. Furthermore, the portfolio is primarily composed of equity securities.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$50.21+$0.76 (+1.54%)
Victory Sycamore Established Value Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
$38.15+$0.10 (+0.26%)
GMO Quality Fund’s quoted price sits in the upper half of its reported 52-week range, 0.99% below the high.
$30.60$0.00 (0.0%)
BlackRock LifePath Index 2050 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.42% below the high.
$27.44-$0.09 (-0.33%)
MFS Research International R2’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
$28.54$0.00 (0.0%)
BlackRock LifePath Index 2045 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.26% below the high.
$116.21+$1.83 (+1.6%)
Vanguard Tax-Managed Small-Cap Fund Admiral Shares’s quoted price sits in the upper half of its reported 52-week range, 5.45% below the high.
$58.31-$0.08 (-0.14%)
Columbia Balanced Fund’s quoted price sits in the upper half of its reported 52-week range, 1.77% below the high.
$36.75-$0.11 (-0.3%)
Principal LargeCap S&P 500 Index Fund’s quoted price sits in the upper half of its reported 52-week range, 1.26% below the high.
